| Literature DB >> 28408795 |
Virginia Filipello1, Ettore Amato2, Maria Gori2, Pol Huedo2, Giulia Ciceri2, Sara Lomonaco1, Mirella Pontello2.
Abstract
In developed countries, pregnancy-related listeriosis accounts for 20-43% of total invasive listeriosis. This work describes the first pregnancy-related listeriosis survey in Italy based on two data sources, that is, mandatory notification system and regional laboratory-based network. Out of 610 listeriosis cases reported over a 10-year period, 40 were pregnancy-related (6.6%). Among these, 29 pregnancy-related isolates were available and have been analysed with serotyping, Pulsed-Field Gel Electrophoresis, and Multi-Virulence-Locus Sequence Typing. No maternal fatality was recorded, but 11 (29.7%) pregnancies resulted in a foetal death, a miscarriage, or a birth of a foetus dying immediately after birth. The average incidence of pregnancy-related listeriosis was 4.3 cases per 100000 births, and the proportion of pregnancy-associated listeriosis among ethnic minorities was significantly higher compared to the general population (30.0% versus 3.5%, P < 0.01). L. monocytogenes isolates belonged to serotypes 1/2a, 1/2b, and 4b, with the latter significantly more prevalent among pregnancy-related isolates. Twenty different pulsotypes were distinguished and 16 out of the 29 isolates were classified into seven clusters. A total of 16 virulence types (VTs) were identified. Five VTs accounted for 45% of the total cases and coincided with those of previously described Epidemic Clones (ECs) of L. monocytogenes.Entities:
Mesh:
Substances:
Year: 2017 PMID: 28408795 PMCID: PMC5376427 DOI: 10.1155/2017/6479121
Source DB: PubMed Journal: Infect Dis Obstet Gynecol ISSN: 1064-7449
Demographic and clinical data of the 40 pregnancy-related listeriosis observed in Lombardy, Italy from 2005 to 2014.
| Characteristics | Number of cases (%) |
|---|---|
| Ethnicity | |
| Italian | 28 (70.0) |
| Foreign | 12 (30.0) |
| Gestational week | |
| 1–12 | 0 (0) |
| 13–24 | 5 (12.5) |
| >24 | 32 (80.0) |
| Unknown | 3 (7.5) |
| Evidence of infection | |
| Only in the mother | 17 (42.5) |
| Only in the foetus/newborn | 19 (47.5) |
| Both | 4 (10.0) |
| Outcome of pregnancy± | |
| Live birth | 26 (70.3) |
| Stillbirth | 4 (10.8) |
| Miscarriage | 7 (18.9) |
| Fatality rate± | 11 (29.7) |
Sites of infection with a positive culture were as follows:
(i) Blood (7), placenta (5), liquor (1), others (7), and unknown sites (1) for maternal infection.
(ii) Blood (12), foetal exudate (1), faeces (1), gastric aspirates (1), ear (2), pharynx (2), skin (1), cerebrospinal fluid (1), rectum (1), and others (1) for foetal-neonatal listeriosis.
±The pregnancy outcome was known for 37 cases only.
Figure 1Number of pregnancy-related listeriosis per 100000 births observed in Lombardy, Italy, from 2005 to 2014.
Figure 2Geographical distribution of pregnancy-related listeriosis cases (per 100000 births) observed in Lombardy, Italy, from 2005 to 2014. BG: Bergamo; BS: Brescia; CO: Como; CR: Cremona; LC: Lecco; LO: Lodi; MN: Mantua; MI: Milan; MB: Monza Brianza; PV: Pavia; SO: Sondrio; VA: Varese.
Serotyping and molecular subtyping results for the 29 pregnancy-related isolates under study (2005–2014, Lombardy, Italy).
| Isolate | Year | Source | Serotype | PFGE | VT | EC | ||
|---|---|---|---|---|---|---|---|---|
| Cluster | Cluster B | p/tc° | ||||||
| LMO 150 | 2010 | Foetus, intestinal content | 4b | B | 2 | 4/27 | 87 | |
| LMO 202 | 2011 | Mother, blood | 4b | 20 | I | |||
| LMO 5 | 2005 | Mother, blood | 4b | C | 20 | I | ||
| LMO 215 | 2012 | Foetus, exudate | 4b | 20 | I | |||
|
| ||||||||
| LMO 305 | 2014 | Foetus, blood | 4b | — | 3 | 2/9 | 20 | I |
| LMO 292 | 2014 | Foetus, blood | 4b | — | 20 | I | ||
|
| ||||||||
| LMO 143 | 2010 | Mother, blood | 4b | G | 5 | 2/15 | 21 | IV |
| LMO 206 | 2011 | Foetus, blood | 4b | 21 | IV | |||
|
| ||||||||
| LMO 13 | 2006 | Foetus, pharynx | 4b | — | 6 | 4/5 | 76 | |
| LMO 38 | 2007 | Foetus, CSF | 4b | F | 76 | |||
| LMO 131 | 2010 | Mother, blood | 4b | 101 | ||||
| LMO 149 | 2010 | Foetus, pharynx | 4b | 19 | II | |||
|
| ||||||||
| LMO 63 | 2008 | Foetus, pharynx | 1/2a | — | 8 | 1/12 | 74 | |
|
| ||||||||
| LMO 42 | 2008 | Placenta | 1/2a | — | 9 | 5/30 | 100 | |
| LMO 217 | 2012 | Placenta | 1/2a | — | 59 | V | ||
| LMO 19 | 2007 | Foetus, gastric aspirate | 1/2a | A | 59 | V | ||
| LMO 225 | 2012 | Foetus, blood | 1/2a | 59 | V | |||
| LMO 248 | 2013 | Mother, blood | 1/2a | 59 | V | |||
|
| ||||||||
| LMO 108 | 2009 | Foetus, blood | 1/2a | — | U⊗ | 75 | ||
|
| ||||||||
| LMO 230 | 2012 | Placenta | 1/2a | — | 10 | 1/10 | 56 | VII |
|
| ||||||||
| LMO 141 | 2010 | Placenta | 1/2a | — | 11 | 3/47 | 80 | |
| LMO 171 | 2011 | Foetus, blood | 1/2a | — | 104 | |||
| LMO 207 | 2012 | Foetus, blood | 1/2a | — | 80 | |||
|
| ||||||||
| LMO 208 | 2011 | Foetus, blood | 1/2a | D | New profile | 4/18 | 45 | |
| LMO 262 | 2013 | Placenta | 1/2a | 45 | ||||
| LMO 251 | 2013 | Foetus, skin | 1/2a | E | 45 | |||
| LMO 272 | 2013 | Foetus, skin | 1/2a | 45 | ||||
|
| ||||||||
| LMO 144 | 2010 | Foetus, blood | 1/2b | — | U⊗ | 102 | ||
|
| ||||||||
| LMO 146 | 2010 | Mother, blood | 4b | — | U⊗ | 103 | ||
VT: virulence type; EC: Epidemic Clone.
PFGE clusters obtained when considering all listeriosis cases between 2005 and 2014 (pregnancy-related and non-pregnancy-related) numbered as in Mammina et al., 2013 [18].
°p/tc: number of pregnancy-related cases/total cases.
CSF: cerebrospinal fluid.
⊗U: Unclustered.
Figure 3AscI-PFGE restriction patterns of the 29 pregnancy-related isolates of L. monocytogenes, Lombardy, Italy, 2004–2015. Clusters with ≥90% similarity are highlighted by orange boxes and identified with a letter.
Figure 4Unrooted neighbor-joining tree computed in MEGA6 [26] for Multi-Virulence-Locus Sequence Typing data obtained for the 29 pregnancy-related isolates of Listeria monocytogenes isolates collected in Lombardy, Italy, from 2005 to 2014. Green indicates isolates of serotype 4b and orange corresponds to isolates of serotype 1/2a. Epidemic Clones (ECs) and non-ECs virulence type (VT) reference strains are highlighted in pink and blue, respectively.